Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 8552  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed12980    
    Printed524    
    Emailed31    
    PDF Downloaded393    
    Comments [Add]    
    Cited by others 26    

Recommend this journal

 

 
Year : 2000  |  Volume : 48  |  Issue : 3  |  Page : 223--6

A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.


Departments of Neurosurgery, Clinical Pharmacology and Neurology, Guntur Medical College, Guntur, Andhra Pradesh, 522001, India., India

Correspondence Address:
B S Rao
Departments of Neurosurgery, Clinical Pharmacology and Neurology, Guntur Medical College, Guntur, Andhra Pradesh, 522001, India.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 11025624

Rights and PermissionsRights and Permissions

Role of propranolol and cyproheptadine in the prophylaxis of migraine was studied in a controlled double blind trial. Two hundred fifty-nine patients were divided into four groups. Each group was either given a placebo, cyproheptadine, propranolol or a combination of the latter two drugs. The patients were followed for a period of three months. Significant relief in frequency, duration and severity from migranous attacks was seen in all drug treated groups over placebo. Significant correlation in response was seen in frequency, duration and severity in all the groups which received drugs. Statistically more significant relief was seen in cyproheptadine and propranolol treated group as compared to individual drug treated groups. In cyproheptadine and propranolol treated groups, the dropout rate was lower and associated symptoms were better relieved than in other groups. The study shows efficacy of combination of cyproheptadine and propranolol in migraine prophylaxis.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow